Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | DHODH | Q02127 | 1/20 | 0.54 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | PARP1 | P09874 | 1/20 | 0.47 |
| ▸ | CASR | P41180 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | ALB | P02768 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26659418 | 1.00 | KDM4E (0.56) | KDM4EALDH1A1CYP1A2CYP2C19DHODH | |
| SCHEMBL30810149 | 0.82 | ALDH1A1 (0.63) | KDM4EALDH1A1DHODHTRPM8SMN1; SMN2 | |
| SCHEMBL2350642 | 0.80 | KDM4E (0.54) | KDM4EALDH1A1CYP1A2DHODHTRPM8 | |
| SCHEMBL26659382 | 0.79 | KDM4E (0.50) | KDM4EALDH1A1CYP1A2CYP2C19DHODH | |
| SCHEMBL26659445 | 0.79 | KDM4E (0.50) | KDM4EALDH1A1CYP1A2CYP2C19DHODH | |
| SCHEMBL4290828 | 0.79 | KDM4E (0.59) | KDM4EALDH1A1CYP1A2CYP2C19DHODH | |
| SCHEMBL12850382 | 0.78 | GAA (0.58) | KDM4EALDH1A1CYP1A2CYP2C19DHODH | |
| SCHEMBL5177083 | 0.78 | GAA (0.58) | KDM4EALDH1A1CYP1A2CYP2C19DHODH | |
| SCHEMBL15412073 | 0.78 | GAA (0.58) | KDM4EALDH1A1CYP1A2CYP2C19DHODH | |
| SCHEMBL10341608 | 0.78 | ALDH1A1 (0.55) | KDM4EALDH1A1DHODHTRPM8SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365730-A1 | HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF | KANEKA CORPORATION (JP) | 2023-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365730-A1 | HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF | KDM5C, DHX15, KDM5A | KDM4E 135/4885ALDH1A1 476/4885CYP1A2 519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.